APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tumor MRD Detection Products and Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tumor MRD Detection Products and Services Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchTumor MRD Detection Products and Services Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Tumor MRD Detection Products and Services Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Tumor MRD Detection Products and Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tumor MRD Detection Products and Services Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Tumor MRD Detection Products and Services Market Analysis and Forecast 2026-2032251 pages · $4,950 USD

Market perspective

The global Tumor MRD Detection Products and Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tumor MRD Detection Products and Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tumor MRD Detection Products and Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tumor MRD Detection Products and Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tumor MRD Detection Products and Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tumor MRD Detection Products and Services market include Natera, Guardant Health, SeraCare Life Sciences, Inc. (LGC), Adaptive Biotechnologies, Invitae（ArcherDX）, Cergentis B.V., LexentBio(Foundation Medicine), Genecast and Genetron Health, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Tumor MRD Detection Products and Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tumor MRD Detection Products and Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tumor MRD Detection Products and Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Tumor MRD Detection Products and Services market.

Tumor MRD Detection Products and Services Segment by Company

Natera

Guardant Health

SeraCare Life Sciences, Inc. (LGC)

Adaptive Biotechnologies

Invitae（ArcherDX）

Cergentis B.V.

LexentBio(Foundation Medicine)

Genecast

Genetron Health

Acornmed

Shenzhen Neoimmune Co., Ltd.

Tung Tree Gene

Geneseeq

BGI Genomics

Burning Rock Biotech Limited

GenePlus

Tumor MRD Detection Products and Services Segment by Type

MRD Detection Products

In Vitro Diagnostic (IVD) Test Service

Tumor MRD Detection Products and Services Segment by Application

Lung Cancer

Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer)

Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer)

Urinary System Tumors (Bladder Cancer)

Central Nervous System Tumors

Soft Tissue and Bone Tumors

Thyroid Cancer and Melanoma

Tumor MRD Detection Products and Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Tumor MRD Detection Products and Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Tumor MRD Detection Products and Services key companies, revenue, market share, and recent developments.

3. To split the Tumor MRD Detection Products and Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Tumor MRD Detection Products and Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tumor MRD Detection Products and Services significant trends, drivers, influence factors in global and regions.

6. To analyze Tumor MRD Detection Products and Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor MRD Detection Products and Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tumor MRD Detection Products and Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor MRD Detection Products and Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tumor MRD Detection Products and Services industry.

Chapter 3: Detailed analysis of Tumor MRD Detection Products and Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Tumor MRD Detection Products and Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Tumor MRD Detection Products and Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tumor MRD Detection Products and Services Industry Trends Table 2. Tumor MRD Detection Products and Services Industry Drivers Table 3. Tumor MRD Detection Products and Services Industry Opportunities and Challenges Table 4. Tumor MRD Detection Products and Services Industry Restraints Table 5. Global Tumor MRD Detection Products and Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tumor MRD Detection Products and Services Revenue Share by Company (2021-2026) Table 7. Global Tumor MRD Detection Products and Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Tumor MRD Detection Products and Services Key Company Manufacturing Base & Headquarters Table 9. Global Tumor MRD Detection Products and Services Company, Product Type & Application Table 10. Global Tumor MRD Detection Products and Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Tumor MRD Detection Products and Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of MRD Detection Products Table 15. Significant Companies of In Vitro Diagnostic (IVD) Test Service Table 16. Global Tumor MRD Detection Products and Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Tumor MRD Detection Products and Services Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Tumor MRD Detection Products and Services Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Tumor MRD Detection Products and Services Sales Value Share by Type (2021-2026) Table 20. Global Tumor MRD Detection Products and Services Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Lung Cancer Table 22. Significant Companies of Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer) Table 23. Significant Companies of Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer) Table 24. Significant Companies of Urinary System Tumors (Bladder Cancer) Table 25. Significant Companies of Central Nervous System Tumors Table 26. Significant Companies of Soft Tissue and Bone Tumors Table 27. Significant Companies of Thyroid Cancer and Melanoma Table 28. Global Tumor MRD Detection Products and Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Tumor MRD Detection Products and Services Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Tumor MRD Detection Products and Services Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Tumor MRD Detection Products and Services Sales Value Share by Application (2021-2026) Table 32. Global Tumor MRD Detection Products and Services Sales Value Share by Application (2027-2032) Table 33. Global Tumor MRD Detection Products and Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Tumor MRD Detection Products and Services Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Tumor MRD Detection Products and Services Sales Value Share by Region (2021-2026) Table 36. Global Tumor MRD Detection Products and Services Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Tumor MRD Detection Products and Services Sales Value Share by Region (2027-2032) Table 38. Global Tumor MRD Detection Products and Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Tumor MRD Detection Products and Services Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Tumor MRD Detection Products and Services Sales Value Market Share by Country (2021-2026) Table 41. Global Tumor MRD Detection Products and Services Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Tumor MRD Detection Products and Services Sales Value Market Share by Country (2027-2032) Table 43. Natera Company Information Table 44. Natera Business Overview Table 45. Natera Tumor MRD Detection Products and Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Natera Tumor MRD Detection Products and Services Product Portfolio Table 47. Natera Recent Development Table 48. Guardant Health Company Information Table 49. Guardant Health Business Overview Table 50. Guardant Health Tumor MRD Detection Products and Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Guardant Health Tumor MRD Detection Products and Services Product Portfolio Table 52. Guardant Health Recent Development Table 53. SeraCare Life Sciences, Inc. (LGC) Company Information Table 54. SeraCare Life Sciences, Inc. (LGC) Business Overview Table 55. SeraCare Life Sciences, Inc. (LGC) Tumor MRD Detection Products and Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. SeraCare Life Sciences, Inc. (LGC) Tumor MRD Detection Products and Services Product Portfolio Table 57. SeraCare Life Sciences, Inc. (LGC) Recent Development Table 58. Adaptive Biotechnologies Company Information Table 59. Adaptive Biotechnologies Business Overview Table 60. Adaptive Biotechnologies Tumor MRD Detection Products and Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Adaptive Biotechnologies Tumor MRD Detection Products and Services Product Portfolio Table 62. Adaptive Biotechnologies Recent Development Table 63. Invitae（ArcherDX） Company Information Table 64. Invitae（ArcherDX） Business Overview Table 65. Invitae（ArcherDX） Tumor MRD Detection Products and Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Invitae（ArcherDX） Tumor MRD Detection Products and Services Product Portfolio Table 67. Invitae（ArcherDX） Recent Development Table 68. Cergentis B.V. Company Information Table 69. Cergentis B.V. Business Overview Table 70. Cergentis B.V. Tumor MRD Detection Products and Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Cergentis B.V. Tumor MRD Detection Products and Services Product Portfolio Table 72. Cergentis B.V. Recent Development Table 73. LexentBio(Foundation Medicine) Company Information Table 74. LexentBio(Foundation Medicine) Business Overview Table 75. LexentBio(Foundation Medicine) Tumor MRD Detection Products and Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. LexentBio(Foundation Medicine) Tumor MRD Detection Products and Services Product Portfolio Table 77. LexentBio(Foundation Medicine) Recent Development Table 78. Genecast Company Information Table 79. Genecast Business Overview Table 80. Genecast Tumor MRD Detection Products and Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Genecast Tumor MRD Detection Products and Services Product Portfolio Table 82. Genecast Recent Development Table 83. Genetron Health Company Information Table 84. Genetron Health Business Overview Table 85. Genetron Health Tumor MRD Detection Products and Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Genetron Health Tumor MRD Detection Products and Services Product Portfolio Table 87. Genetron Health Recent Development Table 88. Acornmed Company Information Table 89. Acornmed Business Overview Table 90. Acornmed Tumor MRD Detection Products and Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Acornmed Tumor MRD Detection Products and Services Product Portfolio Table 92. Acornmed Recent Development Table 93. Shenzhen Neoimmune Co., Ltd. Company Information Table 94. Shenzhen Neoimmune Co., Ltd. Business Overview Table 95. Shenzhen Neoimmune Co., Ltd. Tumor MRD Detection Products and Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Shenzhen Neoimmune Co., Ltd. Tumor MRD Detection Products and Services Product Portfolio Table 97. Shenzhen Neoimmune Co., Ltd. Recent Development Table 98. Tung Tree Gene Company Information Table 99. Tung Tree Gene Business Overview Table 100. Tung Tree Gene Tumor MRD Detection Products and Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Tung Tree Gene Tumor MRD Detection Products and Services Product Portfolio Table 102. Tung Tree Gene Recent Development Table 103. Geneseeq Company Information Table 104. Geneseeq Business Overview Table 105. Geneseeq Tumor MRD Detection Products and Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Geneseeq Tumor MRD Detection Products and Services Product Portfolio Table 107. Geneseeq Recent Development Table 108. BGI Genomics Company Information Table 109. BGI Genomics Business Overview Table 110. BGI Genomics Tumor MRD Detection Products and Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. BGI Genomics Tumor MRD Detection Products and Services Product Portfolio Table 112. BGI Genomics Recent Development Table 113. Burning Rock Biotech Limited Company Information Table 114. Burning Rock Biotech Limited Business Overview Table 115. Burning Rock Biotech Limited Tumor MRD Detection Products and Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Burning Rock Biotech Limited Tumor MRD Detection Products and Services Product Portfolio Table 117. Burning Rock Biotech Limited Recent Development Table 118. GenePlus Company Information Table 119. GenePlus Business Overview Table 120. GenePlus Tumor MRD Detection Products and Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. GenePlus Tumor MRD Detection Products and Services Product Portfolio Table 122. GenePlus Recent Development Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Tumor MRD Detection Products and Services Product Image Figure 2. Global Tumor MRD Detection Products and Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tumor MRD Detection Products and Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Tumor MRD Detection Products and Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. MRD Detection Products Image Figure 8. In Vitro Diagnostic (IVD) Test Service Image Figure 9. Global Tumor MRD Detection Products and Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Tumor MRD Detection Products and Services Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Tumor MRD Detection Products and Services Sales Value Share by Type (2021-2032) Figure 12. Lung Cancer Image Figure 13. Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer) Image Figure 14. Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer) Image Figure 15. Urinary System Tumors (Bladder Cancer) Image Figure 16. Central Nervous System Tumors Image Figure 17. Soft Tissue and Bone Tumors Image Figure 18. Thyroid Cancer and Melanoma Image Figure 19. Global Tumor MRD Detection Products and Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Tumor MRD Detection Products and Services Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Tumor MRD Detection Products and Services Sales Value Share by Application (2021-2032) Figure 22. Global Tumor MRD Detection Products and Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Tumor MRD Detection Products and Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Tumor MRD Detection Products and Services Sales Value (2021-2032) & (US$ Million) Figure 25. North America Tumor MRD Detection Products and Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Tumor MRD Detection Products and Services Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Tumor MRD Detection Products and Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Tumor MRD Detection Products and Services Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Tumor MRD Detection Products and Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Tumor MRD Detection Products and Services Sales Value (2021-2032) & (US$ Million) Figure 31. South America Tumor MRD Detection Products and Services Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Tumor MRD Detection Products and Services Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Tumor MRD Detection Products and Services Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • MRD Detection Products
  • In Vitro Diagnostic (IVD) Test Service
Applications
  • Lung Cancer
  • Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer)
  • Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer)
  • Urinary System Tumors (Bladder Cancer)
  • Central Nervous System Tumors
  • Soft Tissue and Bone Tumors
  • Thyroid Cancer and Melanoma
Companies covered
  • Natera
  • Guardant Health
  • SeraCare Life Sciences, Inc. (LGC)
  • Adaptive Biotechnologies
  • Invitae（ArcherDX）
  • Cergentis B.V.
  • LexentBio(Foundation Medicine)
  • Genecast
  • Genetron Health
  • Acornmed
  • Shenzhen Neoimmune Co., Ltd.
  • Tung Tree Gene
  • Geneseeq
  • BGI Genomics
  • Burning Rock Biotech Limited
  • GenePlus

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tumor MRD Detection Products and Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tumor MRD Detection Products and Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Tumor MRD Detection Products and Services Market Dynamics
  1. 2.1 Tumor MRD Detection Products and Services Industry Trends
  2. 2.2 Tumor MRD Detection Products and Services Industry Drivers
  3. 2.3 Tumor MRD Detection Products and Services Industry Opportunities and Challenges
  4. 2.4 Tumor MRD Detection Products and Services Industry Restraints
3 Tumor MRD Detection Products and Services Market by Company
  1. 3.1 Global Tumor MRD Detection Products and Services Company Revenue Ranking in 2025
  2. 3.2 Global Tumor MRD Detection Products and Services Revenue by Company (2021-2026)
  3. 3.3 Global Tumor MRD Detection Products and Services Company Ranking (2024-2026)
  4. 3.4 Global Tumor MRD Detection Products and Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Tumor MRD Detection Products and Services Company Product Type and Application
  6. 3.6 Global Tumor MRD Detection Products and Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Tumor MRD Detection Products and Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Tumor MRD Detection Products and Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Tumor MRD Detection Products and Services Market by Type
  1. 4.1 Tumor MRD Detection Products and Services Type Introduction
  2. 4.1.1 MRD Detection Products
  3. 4.1.2 In Vitro Diagnostic (IVD) Test Service
  4. 4.2 Global Tumor MRD Detection Products and Services Sales Value by Type
  5. 4.2.1 Global Tumor MRD Detection Products and Services Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tumor MRD Detection Products and Services Sales Value by Type (2021-2032)
  7. 4.2.3 Global Tumor MRD Detection Products and Services Sales Value Share by Type (2021-2032)
5 Tumor MRD Detection Products and Services Market by Application
  1. 5.1 Tumor MRD Detection Products and Services Application Introduction
  2. 5.1.1 Lung Cancer
  3. 5.1.2 Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer)
  4. 5.1.3 Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer)
  5. 5.1.4 Urinary System Tumors (Bladder Cancer)
  6. 5.1.5 Central Nervous System Tumors
  7. 5.1.6 Soft Tissue and Bone Tumors
  8. 5.1.7 Thyroid Cancer and Melanoma
  9. 5.2 Global Tumor MRD Detection Products and Services Sales Value by Application
  10. 5.2.1 Global Tumor MRD Detection Products and Services Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.2.2 Global Tumor MRD Detection Products and Services Sales Value by Application (2021-2032)
  12. 5.2.3 Global Tumor MRD Detection Products and Services Sales Value Share by Application (2021-2032)
6 Tumor MRD Detection Products and Services Regional Value Analysis
  1. 6.1 Global Tumor MRD Detection Products and Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tumor MRD Detection Products and Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Tumor MRD Detection Products and Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Tumor MRD Detection Products and Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tumor MRD Detection Products and Services Sales Value (2021-2032)
  7. 6.3.2 North America Tumor MRD Detection Products and Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Tumor MRD Detection Products and Services Sales Value (2021-2032)
  10. 6.4.2 Europe Tumor MRD Detection Products and Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Tumor MRD Detection Products and Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Tumor MRD Detection Products and Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Tumor MRD Detection Products and Services Sales Value (2021-2032)
  16. 6.6.2 South America Tumor MRD Detection Products and Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Tumor MRD Detection Products and Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Tumor MRD Detection Products and Services Sales Value Share by Country, 2025 VS 2032
7 Tumor MRD Detection Products and Services Country-level Value Analysis
  1. 7.1 Global Tumor MRD Detection Products and Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tumor MRD Detection Products and Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Tumor MRD Detection Products and Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Tumor MRD Detection Products and Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Tumor MRD Detection Products and Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Tumor MRD Detection Products and Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Tumor MRD Detection Products and Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Natera
  2. 8.1.1 Natera Company Information
  3. 8.1.2 Natera Business Overview
  4. 8.1.3 Natera Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Natera Tumor MRD Detection Products and Services Product Portfolio
  6. 8.1.5 Natera Recent Developments
  7. 8.2 Guardant Health
  8. 8.2.1 Guardant Health Company Information
  9. 8.2.2 Guardant Health Business Overview
  10. 8.2.3 Guardant Health Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Guardant Health Tumor MRD Detection Products and Services Product Portfolio
  12. 8.2.5 Guardant Health Recent Developments
  13. 8.3 SeraCare Life Sciences, Inc. (LGC)
  14. 8.3.1 SeraCare Life Sciences, Inc. (LGC) Company Information
  15. 8.3.2 SeraCare Life Sciences, Inc. (LGC) Business Overview
  16. 8.3.3 SeraCare Life Sciences, Inc. (LGC) Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SeraCare Life Sciences, Inc. (LGC) Tumor MRD Detection Products and Services Product Portfolio
  18. 8.3.5 SeraCare Life Sciences, Inc. (LGC) Recent Developments
  19. 8.4 Adaptive Biotechnologies
  20. 8.4.1 Adaptive Biotechnologies Company Information
  21. 8.4.2 Adaptive Biotechnologies Business Overview
  22. 8.4.3 Adaptive Biotechnologies Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Adaptive Biotechnologies Tumor MRD Detection Products and Services Product Portfolio
  24. 8.4.5 Adaptive Biotechnologies Recent Developments
  25. 8.5 Invitae（ArcherDX）
  26. 8.5.1 Invitae（ArcherDX） Company Information
  27. 8.5.2 Invitae（ArcherDX） Business Overview
  28. 8.5.3 Invitae（ArcherDX） Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Invitae（ArcherDX） Tumor MRD Detection Products and Services Product Portfolio
  30. 8.5.5 Invitae（ArcherDX） Recent Developments
  31. 8.6 Cergentis B.V.
  32. 8.6.1 Cergentis B.V. Company Information
  33. 8.6.2 Cergentis B.V. Business Overview
  34. 8.6.3 Cergentis B.V. Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cergentis B.V. Tumor MRD Detection Products and Services Product Portfolio
  36. 8.6.5 Cergentis B.V. Recent Developments
  37. 8.7 LexentBio(Foundation Medicine)
  38. 8.7.1 LexentBio(Foundation Medicine) Company Information
  39. 8.7.2 LexentBio(Foundation Medicine) Business Overview
  40. 8.7.3 LexentBio(Foundation Medicine) Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LexentBio(Foundation Medicine) Tumor MRD Detection Products and Services Product Portfolio
  42. 8.7.5 LexentBio(Foundation Medicine) Recent Developments
  43. 8.8 Genecast
  44. 8.8.1 Genecast Company Information
  45. 8.8.2 Genecast Business Overview
  46. 8.8.3 Genecast Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Genecast Tumor MRD Detection Products and Services Product Portfolio
  48. 8.8.5 Genecast Recent Developments
  49. 8.9 Genetron Health
  50. 8.9.1 Genetron Health Company Information
  51. 8.9.2 Genetron Health Business Overview
  52. 8.9.3 Genetron Health Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Genetron Health Tumor MRD Detection Products and Services Product Portfolio
  54. 8.9.5 Genetron Health Recent Developments
  55. 8.10 Acornmed
  56. 8.10.1 Acornmed Company Information
  57. 8.10.2 Acornmed Business Overview
  58. 8.10.3 Acornmed Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Acornmed Tumor MRD Detection Products and Services Product Portfolio
  60. 8.10.5 Acornmed Recent Developments
  61. 8.11 Shenzhen Neoimmune Co., Ltd.
  62. 8.11.1 Shenzhen Neoimmune Co., Ltd. Company Information
  63. 8.11.2 Shenzhen Neoimmune Co., Ltd. Business Overview
  64. 8.11.3 Shenzhen Neoimmune Co., Ltd. Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shenzhen Neoimmune Co., Ltd. Tumor MRD Detection Products and Services Product Portfolio
  66. 8.11.5 Shenzhen Neoimmune Co., Ltd. Recent Developments
  67. 8.12 Tung Tree Gene
  68. 8.12.1 Tung Tree Gene Company Information
  69. 8.12.2 Tung Tree Gene Business Overview
  70. 8.12.3 Tung Tree Gene Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Tung Tree Gene Tumor MRD Detection Products and Services Product Portfolio
  72. 8.12.5 Tung Tree Gene Recent Developments
  73. 8.13 Geneseeq
  74. 8.13.1 Geneseeq Company Information
  75. 8.13.2 Geneseeq Business Overview
  76. 8.13.3 Geneseeq Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Geneseeq Tumor MRD Detection Products and Services Product Portfolio
  78. 8.13.5 Geneseeq Recent Developments
  79. 8.14 BGI Genomics
  80. 8.14.1 BGI Genomics Company Information
  81. 8.14.2 BGI Genomics Business Overview
  82. 8.14.3 BGI Genomics Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BGI Genomics Tumor MRD Detection Products and Services Product Portfolio
  84. 8.14.5 BGI Genomics Recent Developments
  85. 8.15 Burning Rock Biotech Limited
  86. 8.15.1 Burning Rock Biotech Limited Company Information
  87. 8.15.2 Burning Rock Biotech Limited Business Overview
  88. 8.15.3 Burning Rock Biotech Limited Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Burning Rock Biotech Limited Tumor MRD Detection Products and Services Product Portfolio
  90. 8.15.5 Burning Rock Biotech Limited Recent Developments
  91. 8.16 GenePlus
  92. 8.16.1 GenePlus Company Information
  93. 8.16.2 GenePlus Business Overview
  94. 8.16.3 GenePlus Tumor MRD Detection Products and Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 GenePlus Tumor MRD Detection Products and Services Product Portfolio
  96. 8.16.5 GenePlus Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst